4.6 Article

Virologic and Immunologic Evidence of Multifocal Genital Herpes Simplex Virus 2 Infection

Journal

JOURNAL OF VIROLOGY
Volume 88, Issue 9, Pages 4921-4931

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.03285-13

Keywords

-

Categories

Funding

  1. Aicuris GmbH
  2. Gilead
  3. Agenus
  4. Genocea
  5. National Institutes of Health [K23 AI079394, K24 AI071113, P01 AI30731, R56 AI093746, R01 AI042528, R01 AI 094019]

Ask authors/readers for more resources

Genital herpes simplex virus (HSV) reactivation is thought to be anatomically and temporally localized, coincident with limited ganglionic infection. Short, subclinical shedding episodes are the most common form of HSV-2 reactivation, with host clearance mechanisms leading to rapid containment. The anatomic distribution of shedding episodes has not been characterized. To precisely define patterns of anatomic reactivation, we divided the genital tract into a 22-region grid and obtained daily swabs for 20 days from each region in 28 immunocompetent, HSV-2-seropositive persons. HSV was detected via PCR, and sites of asymptomatic HSV shedding were subjected to a biopsy procedure within 24 h. CD4(+) and CD8(+) T cells were quantified by immunofluorescence, and HSV-specific CD4(+) T cells were identified by intracellular cytokine cytometry. HSV was detected in 868 (7%) of 11,603 genital swabs at a median of 12 sites per person (range, 0 to 22). Bilateral HSV detection occurred on 83 (67%) days with shedding, and the median quantity of virus detected/day was associated with the number of sites positive (P<0.001). In biopsy specimens of asymptomatic shedding sites, we found increased numbers of CD8(+) T cells compared to control tissue (27 versus 13 cells/mm(2), P = 0.03) and identified HSV-specific CD4(+) T cells. HSV reactivations emanate from widely separated anatomic regions of the genital tract and are associated with a localized cellular infiltrate that was demonstrated to be HSV specific in 3 cases. These data provide evidence that asymptomatic HSV-2 shedding contributes to chronic inflammation throughout the genital tract.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

CD4 and CD8 co-receptors modulate functional avidity of CD1b-restricted T cells

Charlotte A. James, Yuexin Xu, Melissa S. Aguilar, Lichen Jing, Erik D. Layton, Martine Gilleron, Adriaan J. Minnaard, Thomas J. Scriba, Cheryl L. Day, Edus H. Warren, David M. Koelle, Chetan Seshadri

Summary: This study reveals the importance of CD4 and CD8 co-receptors in recognizing mycobacterial glycolipid antigens. The expression of either CD4 or CD8 increases the avidity of T cell receptors for mycolipids, leading to a higher intensity of fluorescence and decreased secretion threshold for interferon-gamma. Furthermore, CD8+ T cells show greater cytotoxicity compared to CD4+ T cells in individuals with active tuberculosis.

NATURE COMMUNICATIONS (2022)

Article Virology

HLA-B*57:01 Complexed to a CD8 T-Cell Epitope from the HSV-2 ICP22 Protein Binds NK and T Cells through KIR3DL1

Kerry J. Laing, Victoria L. Campbell, Lichun Dong, David M. Koelle

Summary: HLA-B*57:01 is associated with positive outcomes during viral infections through interactions with T cells and NK cells, but can lead to severe disease when treated with the anti-HIV-1 drug abacavir. In this study, a CD8 T-cell epitope in the ICP22 (US1) protein of HSV-2 that is restricted by HLA-B*57:01 was identified. The tetramer of this epitope was found to bind both CD8 T cells and NK cells, suggesting a mechanism for the recognition of HSV infection by NK cells or KIR-expressing T cells via KIR3DL1.

VIRUSES-BASEL (2022)

Article Medicine, Research & Experimental

Hydroxychloroquine for treatment of non-hospitalized adults with COVID-19: A meta-analysis of individual participant data of randomized trials

Oriol Mitja, Gilmar Reis, David R. Boulware, Adam M. Spivak, Ammar Sarwar, Christine Johnston, Brandon Webb, Michael D. Hill, Davey Smith, Peter Kremsner, Marla Curran, David Carter, Jim Alexander, Marc Corbacho, Todd C. Lee, Katherine Huppler Hullsiek, Emily G. McDonald, Rachel Hess, Michael Hughes, Jared M. Baeten, Ilan Schwartz, Luanne Metz, Lawrence Richer, Kara W. Chew, Eric Daar, David Wohl, Michael Dunne

Summary: This study conducted a pooled analysis of individual participant data from 11 randomized controlled trials to evaluate the efficacy of hydroxychloroquine (HCQ) in outpatients with mild COVID-19. The results suggest that HCQ does not show significant effects on viral clearance and hospitalization rate, and therefore, the use of HCQ in mild COVID-19 outpatients should be discontinued to reduce the risk of disease progression.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Medicine, General & Internal

Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study

Sachin Silva, Houssein H. Ayoub, Christine Johnston, Rifat Atun, Laith J. Abu-Raddad

Summary: This study estimated the economic and quality-of-life losses due to genital herpes in low- and middle-income countries (LMICs) and the potential contribution of herpes simplex virus type 2 (HSV-2) infections to HIV transmission. The findings showed that the economic losses caused by genital herpes can be substantial, and the quality-of-life losses outweigh the spending on treatment and productivity reduction. If HSV-2 has indeed contributed to the spread of HIV, then a significant proportion of the costs associated with HIV treatment and wage losses can be attributed to HSV-2. Therefore, developing a vaccine against HSV-2 should be a global priority.

PLOS MEDICINE (2022)

Article Hematology

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

Chaitra Ujjani, Ted A. Gooley, Stephen E. Spurgeon, Deborah M. Stephens, Catherine Lai, Catherine M. Broome, Susan O'Brien, Haiying Zhu, Kerry J. Laing, Allison M. Winter, Georgios Pongas, Alexander L. Greninger, David M. Koelle, Tanya Siddiqi, Matthew S. Davids, Kerry A. Rogers, Alexey V. Danilov, Amy Sperling, Brian Tu, Tyler Sorensen, Kelsey Launchbury, Carlissa J. Burrow, Genesis Quezada, Joshua A. Hill, Mazyar Shadman, Philip A. Thompson

Summary: This study aimed to analyze the immune responses of patients with chronic lymphocytic leukemia (CLL) to the COVID-19 vaccine, including T-cell responses, and the impact of CLL therapeutics. The study found that patients receiving B-cell-directed therapy were less likely to have immune conversion. Additionally, the immune response persisted at 6 months, and administration of booster vaccinations enhanced the immune response. However, caution should be exercised as newer variants emerge and escape vaccine-induced immunity.

BLOOD ADVANCES (2023)

Article Biochemistry & Molecular Biology

A Simultaneous Extraction/Derivatization Strategy for Quantitation of Vitamin D in Dried Blood Spots Using LC-MS/MS: Application to Biomarker Study in Subjects Tested for SARS-CoV-2

Yashpal S. Chhonker, Nusrat Ahmed, Christine M. Johnston, Ruanne V. Barnabas, Daryl J. Murry

Summary: Vitamin D is crucial for bone development and maintenance, as well as other physiological functions. Lower levels of serum vitamin D have been associated with severity of infection in COVID-19 patients. We developed and validated a robust LC-MS/MS method for quantitation of vitamin D and its metabolites in human dried blood spot samples. This method provides sensitive and accurate measurement, and can be applied to investigate the role of these compounds in various physiological processes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Immunology

Varicella-zoster virus proteome-wide T-cell screening demonstrates low prevalence of virus-specific CD8 T-cells in latently infected human trigeminal ganglia

Michiel van Gent, Werner J. D. Ouwendijk, Victoria L. Campbell, Kerry J. Laing, Georges M. G. M. Verjans, David M. Koelle

Summary: This study suggests that VZV-specific CD8 T-cells play a limited role in maintaining latent infection of varicella-zoster virus in human trigeminal ganglia.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Virology

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron

Linhui Hao, Tien-Ying Hsiang, Ronit R. Dalmat, Renee Ireton, Jennifer F. Morton, Caleb Stokes, Jason Netland, Malika Hale, Chris Thouvenel, Anna Wald, Nicholas M. Franko, Kristen Huden, Helen Y. Chu, Alex Sigal, Alex L. Greninger, Sasha Tilles, Lynn K. Barrett, Wesley C. Van Voorhis, Jennifer Munt, Trevor Scobey, Ralph S. Baric, David J. Rawlings, Marion Pepper, Paul K. Drain, Michael Gale

Summary: New variants of SARS-CoV-2 continue to emerge and evade immunity. Convalescence from the ancestral virus provides limited protection against variants. Vaccination enhances immunity against viral variants, but the protection is weaker against Omicron BA.1, and a three-dose vaccine regimen provides significantly better protection against it compared to a two-dose.

VIRUSES-BASEL (2023)

Article Medicine, Research & Experimental

Novel engineered chimeric engulfment receptors trigger T cell effector functions against SIV-infected CD4+T cells

Daniel Corey, Francoise Haeseleer, Joe Hou, Lawrence Corey

Summary: Adoptive therapy using genetically engineered T cells shows promise in treating infectious diseases in immunocompromised individuals. In this study, chimeric engulfment receptor (CER) T cells designed to recognize phosphatidylserine (PS)-expressing cells successfully eliminated SIV-infected cells. The introduction of innate immune functions into T cells enhances the elimination of SIV-infected cells, and further in vivo studies are needed to evaluate their effectiveness.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2023)

Editorial Material Ethics

Ancillary Care Obligations of Clinical Trial Investigators in the COVID-19 Pandemic

Tara M. Babu, Anna Wald

AMERICAN JOURNAL OF BIOETHICS (2023)

Editorial Material Pharmacology & Pharmacy

Human skin-on-a-chip for mpox pathogenesis studies and preclinical drug evaluation

Jia Zhu, Hasan E. Abaci

Summary: The timely intervention of preventative and therapeutic measures has mitigated the global outbreak of mpox in 2022. However, further investigation is needed due to the high transmissibility and unique pathological characteristics of mpox. This article discusses the potential of a human skin-on-a-chip model for evaluating mpox disease, aiming to achieve a comprehensive understanding of its physiology and improve therapeutic predictions.

TRENDS IN PHARMACOLOGICAL SCIENCES (2023)

Article Immunology

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women

Deborah Donnell, Fei Gao, James P. Hughes, Brett Hanscom, Lawrence Corey, Myron S. Cohen, Srilatha Edupuganti, Nyaradzo Mgodi, Helen Rees, Jared M. Baeten, Glenda Gray, Linda-Gail Bekker, Mina Hosseinipour, Sinead Delany-Moretlwe

Summary: This study used counterfactual placebo comparisons using other data sources to evaluate the efficacy of antiretroviral agents for HIV pre-exposure prophylaxis. The findings showed that injectable cabotegravir (CAB-LA) and daily oral emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) can significantly reduce the risk of HIV infection compared to no intervention, and the efficacy of FTC/TDF against counterfactual placebo was consistent with previous placebo-controlled trials.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Immunology

Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19

Emily S. Ford, Koshlan Mayer-Blackwell, Lichen Jing, Kerry J. Laing, Anton M. Sholukh, Russell St. Germain, Emily L. Bossard, Hong Xie, Thomas H. Pulliam, Saumya Jani, Stacy Selke, Carlissa J. Burrow, Christopher L. McClurkan, Anna Wald, Alexander L. Greninger, Michael R. Holbrook, Brett Eaton, Elizabeth Eudy, Michael Murphy, Elena Postnikova, Harlan S. Robins, Rebecca Elyanow, Rachel M. Gittelman, Matyas Ecsedi, Elise Wilcox, Aude G. Chapuis, Andrew Fiore-Gartland, David M. Koelle

Summary: Hybrid immunity, resulting from a combination of vaccination and previous infection, offers greater protection against SARS-CoV-2 than either vaccination or prior infection alone. This study investigated the dynamics of spike-reactive T cells in individuals with hybrid immunity, following either SARS-CoV-2 infection or mRNA vaccination. The findings show that vaccination leads to expansions of memory T cell clones, while also generating diverse new T cell clones. The study provides insights into T cell responses to vaccines and emerging pathogens.

NATURE IMMUNOLOGY (2023)

Article Multidisciplinary Sciences

Modeling human HSV infection via a vascularized immune-competent skin-on-chip platform

Sijie Sun, Lei Jin, Ying Zheng, Jia Zhu

Summary: A vascularized 3D "skin-on-chip" model has been developed to mimic human skin architecture and investigate Herpes simplex virus (HSV) infection, showing that perfusion with an antiviral drug can inhibit the infection.

NATURE COMMUNICATIONS (2022)

Meeting Abstract Medicine, General & Internal

T-CELL AND ANTIBODY RESPONSES TO MRNA VACCINATION IN SARS-COV-2-CONVALESCENT SUBJECTS

S. Wanner, V. L. Campbell, S. Selke, D. M. Koelle

JOURNAL OF INVESTIGATIVE MEDICINE (2022)

No Data Available